BACKGROUND: Peanut allergy is a frequent and potentially life-threatening food allergy. Despite the large taxonomic distance between the plants, peanut-allergic patients often react to tree nuts such as walnuts. While the allergens of peanut and walnut have a high degree of homology in their amino-acid sequences, it is unknown whether this similarity is responsible for the observed co-reactivity. Therefore, we analyzed the binding of specific IgE antibodies to sequential epitopes of peanut and walnut in peanut-allergic patients with and without walnut allergy. METHODS: The IgE binding to previously described sequential epitopes of peanut and the homologous regions of walnut was assessed in 32 peanut-allergic patients using a peptide microarray technology. Twelve patients had a clinically relevant walnut allergy and 20 were tolerant to walnut. Inhibition assays with peanut peptides and corresponding walnut sequences were performed to show specific binding to sequential epitopes. RESULTS: No differences in the recognition of sequential epitopes could be found between peanut-allergic patients with or without walnut allergy. Only a few patients showed IgE binding to walnut sequences that corresponded to sequential epitopes of peanut. In the inhibition assays, no relevant cross-reacting IgE antibodies could be detected for the peptides analyzed. CONCLUSION: Our results indicate that although they share a rather high degree of homology with the corresponding regions of walnut allergens, the sequence stretches previously identified as sequential IgE binding epitopes of Ara h 1, Ara h 2 and Ara h 3 have no IgE binding equivalents in walnut allergens.
BACKGROUND:Peanutallergy is a frequent and potentially life-threatening food allergy. Despite the large taxonomic distance between the plants, peanut-allergicpatients often react to tree nuts such as walnuts. While the allergens of peanut and walnut have a high degree of homology in their amino-acid sequences, it is unknown whether this similarity is responsible for the observed co-reactivity. Therefore, we analyzed the binding of specific IgE antibodies to sequential epitopes of peanut and walnut in peanut-allergicpatients with and without walnut allergy. METHODS: The IgE binding to previously described sequential epitopes of peanut and the homologous regions of walnut was assessed in 32 peanut-allergicpatients using a peptide microarray technology. Twelve patients had a clinically relevant walnut allergy and 20 were tolerant to walnut. Inhibition assays with peanut peptides and corresponding walnut sequences were performed to show specific binding to sequential epitopes. RESULTS: No differences in the recognition of sequential epitopes could be found between peanut-allergicpatients with or without walnut allergy. Only a few patients showed IgE binding to walnut sequences that corresponded to sequential epitopes of peanut. In the inhibition assays, no relevant cross-reacting IgE antibodies could be detected for the peptides analyzed. CONCLUSION: Our results indicate that although they share a rather high degree of homology with the corresponding regions of walnut allergens, the sequence stretches previously identified as sequential IgE binding epitopes of Ara h 1, Ara h 2 and Ara h 3 have no IgE binding equivalents in walnut allergens.
Authors: Frauke Schocker; Dirk Lüttkopf; Stephan Scheurer; Arnd Petersen; Anna Cisteró-Bahima; Ernesto Enrique; Mar San Miguel-Moncín; Jaap Akkerdaas; Ronald van Ree; Stefan Vieths; Wolf-Meinhard Becker Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Luis Diego Archila; David Jeong; Mariona Pascal; Joan Bartra; Manel Juan; David Robinson; Mary L Farrington; William W Kwok Journal: J Allergy Clin Immunol Date: 2015-03-13 Impact factor: 10.793
Authors: Nanna Juel-Berg; Lau Fabricius Larsen; Niels Küchen; Ida Norgil; Kirsten Skamstrup Hansen; Lars K Poulsen Journal: Front Allergy Date: 2022-03-28
Authors: Jarmila Celakovská; Josef Bukac; Karel Ettler; Jaroslava Vaneckova; Irena Krcmova; Kvetuse Ettlerova; Jan Krejsek Journal: Indian J Dermatol Date: 2019 Sep-Oct Impact factor: 1.494